In CKD, which condition increases the risk of AKI when using ACE inhibitors or ARBs?

Prepare for the Urinary System Pathologies Test with comprehensive quizzes. Master key concepts through flashcards and multiple-choice questions. Boost your confidence and be exam-ready!

Multiple Choice

In CKD, which condition increases the risk of AKI when using ACE inhibitors or ARBs?

Explanation:
The main concept is how ACE inhibitors and ARBs affect kidney hemodynamics when renal arteries are narrowed. In kidneys with renal artery stenosis, especially when both kidneys are affected, angiotensin II helps maintain glomerular filtration by constricting the efferent arteriole. Blocking angiotensin II with these drugs removes this compensatory constriction, lowering glomerular pressure and GFR. When both kidneys rely on this mechanism, the drop in filtration pressure can precipitate acute kidney injury. If only one kidney is stenotic, the other kidney can compensate and AKI is less likely. Hypotension or hypernatremia can occur with these drugs, but the strongest risk factor for AKI in this setting is bilateral renal artery stenosis.

The main concept is how ACE inhibitors and ARBs affect kidney hemodynamics when renal arteries are narrowed. In kidneys with renal artery stenosis, especially when both kidneys are affected, angiotensin II helps maintain glomerular filtration by constricting the efferent arteriole. Blocking angiotensin II with these drugs removes this compensatory constriction, lowering glomerular pressure and GFR. When both kidneys rely on this mechanism, the drop in filtration pressure can precipitate acute kidney injury. If only one kidney is stenotic, the other kidney can compensate and AKI is less likely. Hypotension or hypernatremia can occur with these drugs, but the strongest risk factor for AKI in this setting is bilateral renal artery stenosis.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy